;

House Publications

The Debates are the report—transcribed, edited, and corrected—of what is said in the House. The Journals are the official record of the decisions and other transactions of the House. The Order Paper and Notice Paper contains the listing of all items that may be brought forward on a particular sitting day, and notices for upcoming items.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Bilingual view PDF


Tuesday, May 26, 2020 (No. 38)

Questions

Those questions not appearing in the list have been answered, withdrawn or made into orders for return.

Q-425² — April 16, 2020 — — With regard to government purchases of personal protective equipment (PPE): (a) how many units of PPE did the government have in Canada by November 30, 2019, broken down by type of equipment, and how much PPE was purchased in this month; (b) how many units of PPE did the government have in Canada by December 31, 2019, broken down by type of equipment, and how much PPE was purchased in this month; (c) how many units of PPE did the government have in Canada by January 31, 2020, broken down by type of equipment, and how much PPE was purchased in this month; (d) how many units of PPE did the government have in Canada by February 29, 2020, broken down by type of equipment, and how much PPE was purchased in this month; and (e) how many units of PPE did the government have in Canada by March 31, 2020, broken down by type of equipment, and how much PPE was purchased in this month?

Q-426² — April 16, 2020 — — With regard to additional funding for agencies tasked with Canadian border management, broken down by source of funds and fiscal mechanism (i.e. business of supply, emergency payment from fiscal framework, new legislation): (a) how much went to each border management agency throughout December 2019, broken down by (i) source of funds, (ii) amount of funds, (iii) purpose of funds; (b) how much went to each border management agency throughout January 2020, broken down by (i) source of funds, (ii) amount of funds, (iii) purpose of funds; (c) how much went to each border management agency throughout February 2020, broken down by (i) source of funds, (ii) amount of funds, (iii) purpose of funds; and (d) how much went to each border management agency throughout March 2020, broken down by (i) source of funds, (ii) amount of funds, (iii) purpose of funds?

Q-427² — April 16, 2020 — — With regard to the Canada Emergency Care Benefit: (a) how many people have received payments from both Employment and Social Development Canada and the Canada Revenue Agency; (b) of those cases in (a), how much was paid out in double payments; and (c) how much will need to be recovered due to double payments?

Q-428² — April 16, 2020 — — With regard to meetings or briefings at the deputy minister, minister, and cabinet level for Health Canada, the Public Health Agency of Canada, Global Affairs Canada, the Privy Council Office, Public Safety Canada, and all agencies therein, between November 30, 2019, and March 31, 2020: what were the details of all meetings held referencing the Hubei province in China, the novel coronavirus, COVID-19, pandemics, and emergency preparedness measures, including (i) the department holding the meeting, (ii) the date of meeting, (iii) officials in attendance, (iv) the topic of the meeting or agenda?

Q-429² — April 16, 2020 — — With regard to inmates released early from federal correctional institutions as a result of the COVID-19 pandemic: (a) what is the total number of inmates who were released early; (b) what is the breakdown of (a) by (i) institution, (ii) length of sentence; and (c) how many of the inmates released early were serving sentences related to (i) murder or manslaughter, (ii) sex offences, (iii) other violent crimes?

Q-430² — April 16, 2020 — — With regard to COVID-19: (a) what is the first date on which Canadian Armed Forces MEDINT or CFINTCOM became aware of a new novel coronavirus in China; (b) what is the first date on which the Minister of National Defence was briefed or received a briefing note regarding a new novel coronavirus in China; and (c) what is the first date on which the Minister of National Defence shared information concerning a new novel coronavirus in China with the Prime Minister’s Office and/or the Privy Council Office?

Q-431² — April 16, 2020 — — With regard to personal protective equipment: (a) how many C4 protective masks and canisters have been issued to Canadian Armed Forces (CAF) personnel since January 1, 2020; (b) how many C4 protective masks and canisters are in stockpile; and (c) what are the types and quantities of all personal protective equipment for infectious diseases available for CAF/Department of National Defence personnel and in stockpile?

Q-432² — April 16, 2020 — — With regard to the Mobile Tactical Vehicle Light, Mobile Tactical Vehicle Engineer, Mobile Tactical Vehicle Recovery, and Mobile Tactical Vehicle Fitter: (a) how many of these mobile tactical vehicles have been identified as surplus; (b) how many mobile tactical vehicles have been or are in the process of being decommissioned; (c) how many of these mobile tactical vehicles have been given to museums or sold to private owners; (d) how many of these mobile tactical vehicles remain in service; and (e) by which date does the Canadian Armed Forces/Department of National Defence plan to have the entire fleet of these mobile tactical vehicles removed from service?

Q-433² — April 16, 2020 — — With regard to Role 2 and Role 3 hospitals and air transportation: (a) how many Role 2 and Role 3 hospitals are currently available in Canada; (b) how many Role 2 and Role 3 hospitals are planned for the next six months; and (c) how many aircraft capable of transporting people with infectious disease does the Canadian Armed Forces/Department of National Defence intend to acquire and by which date?

Q-434² — April 16, 2020 — — With respect to the Bank of Canada’s participation in Canada’s economic response to the coronavirus pandemic, between March 1, 2020, and the tabling of the reply to this question: (a) what is the dollar value of securities purchased under the Government of Canada Bond Purchase Program; (b) what is the dollar value of securities purchased under the Canada Mortgage Bond Purchase Program; (c) what is the dollar value of purchases under the Banker’s Acceptance Purchase Facility; (d) what is the dollar value of assets purchased under the Provincial Money Market Purchase Program, by province and in aggregate, respectively; (e) what is the dollar value of purchases under the Provincial Bond Purchase Program; (f) what is the dollar value of purchases under the Corporate Bond Purchase Program; (g) what is the dollar value of purchases under the Commercial Paper Purchase Program; (h) what is the dollar value of purchases under the Contingent Term Repo Facility; (i) what is the projected dollar value for total purchases during the life of each program in (a) to (h); (j) what is the dollar value of new currency created to date to fund the measures taken in (a) to (h); (k) what is the projected dollar value of new currency to be created to fund the measures taken in (a) to (h) during the life of each program; (l) what, if any, effects on inflation by the creation of currency in (j) does the Bank of Canada project for (i) 2020, (ii) 2021, (iii) 2022; and (m) what, if any, adjustments to the Bank of Canada’s prime rate does it anticipate needing to counteract any inflation projected in (l)?

Q-435² — April 16, 2020 — — With respect to the Bank of Canada’s participation in Canada’s economic response to the coronavirus pandemic: (a) when does the Bank of Canada project divesting itself of assets purchased under each of the Government of Canada Bond Purchase Program, the Canada Mortgage Bond Purchase Program, the Banker’s Acceptance Purchase Facility, the Provincial Money Market Purchase Program, the Commercial Paper Purchase Program, and the Contingent Term Repo Facility; and (b) what gain or loss does the Bank of Canada project realizing upon the sale of assets purchased under each of the programs in (a) respectively?

Q-436² — April 16, 2020 — — With respect to the doubling of the carbon tax on April 1, 2020: (a) by how much will the increased tax raise the cost of producing oil and natural gas respectively nationwide; (b) by how much will the increased tax raise the cost of producing oil and natural gas respectively for each energy producing province; (c) by how much have national revenues declined due to the drop in the price of crude oil since January 1, 2020; (d) in order for national revenues to recover to levels immediately pre-dating the drop in the price of oil in (c), and given the increased cost of production in (a), what does the price of crude oil need to be; (e) what effect does the increase in cost of production in (a) have on the ability of Canadian energy producers to compete with foreign producers at current world prices for crude oil; and (f) how many Canadian energy producers does the government forecast will be unable to compete with foreign energy producers at the prevailing price of crude oil due to the increased cost of production in (a)?

Q-437² — April 27, 2020 — — With regard to government grants, contributions and contracts since January 1, 2016, what are the details of all grants, contributions or contracts given to World Wildlife Fund Canada or its international affiliates, broken down by: (a) date issued; (b) description of services provided; (c) authorizer; (d) timeframe for services; (e) original contribution value; (f) final contribution value (if different); (g) location services will be provided; and (h) reference and file number?

Q-438² — April 27, 2020 — — With regard to the budget measure contained in Bill C-44 (42nd Parliament, budget 2017) exempting fees under the Food and Drugs Act from the new rules contained in the Service Fees Act: (a) how many times has the Minister of Health given a ministerial order to increase fees; and (b) what are the details of each increase, broken down by date of ministerial order, including (i) amount of the increase for each drug, device, food or cosmetic, by percentage and absolute dollar value, (ii) amount of the fee, (iii) manner or criteria used for determining the amount, (iv) circumstances in which the fee will be payable, (v)rationale for the fee, (vi) specific factors taken into account in determining the amount of the fee, (vii) performance standard that will apply in respect of the fee?

Q-439² — April 27, 2020 — — With regard to temporary resident permits specific to victims of human trafficking, since November 4, 2015: (a) how many applications have been received; (b) how many temporary resident permits have been issued; (c) how many temporary resident permits were denied; (d) in (a) to (c), what is the breakdown by (i) year, (ii) month, (iii) gender, (iv) source country; (e) for permits in (b), what is the breakdown based on ministerial instructions 1(1), 1(2) and 2; and (f) what is the average wait time for an individual who applies for a temporary resident permits specific to victims of human trafficking?

Q-440² — April 27, 2020 — — With regard to federal funding to combat human trafficking since November 4, 2015: (a) what is the total amount, broken down by (i) department or agency, (ii) initiative, (iii) amount; (b) what process was used to determine which department or agency would receive this funding; (c) what criteria or process was used to determine how much funding was allocated to each department or agency; and (d) what is the itemized list of funding programs to combat human trafficking, including (i) title of program, (ii) recipient organization or name, (iii) date of expenditure, (iv) amount, (vi) description of goods or services provided, including quantity, if applicable, (vi) file number?

Q-441² — April 27, 2020 — — With regard to the additional $75 million National Strategy to Combat Human Trafficking announced on September 4, 2019: (a) what departments and agencies are receiving this new funding, broken down by initiative and organization; (b) what are the details of all funding provided to date, including the (i) name, (ii) project description, (iii) amount, (iv) date of the announcement, (v) duration of the project or program funded by the announcement; (c) what process was used to determine which department or agency would receive this funding; (d) what criteria or process was used to determine how much funding was allocated to each department or agency; and (e) what projects are slated to receive federal funding in the 2020-21 fiscal year?

Q-442² — April 27, 2020 — — With regard to the functioning of the public service and government officials since March 16, 2020: (a) how many employees or full time equivalents (FTEs) have been (i) hired, (ii) reassigned in relation to the COVID-19 response; (b) how many FTEs have been (i) working from a government building, (ii) telecommuting or working from home during the pandemic; and (c) how many FTEs have been (i) laid off or terminated, (ii) placed on leave, broken down by type of leave?

Q-443² — May 11, 2020 — — With regard to construction and renovations at the Prime Minister’s country residence and surrounding property at Harrington Lake: (a) what are the details of each new building or other structure constructed, or in the process of being constructed, at the property since November 4, 2015, including (i) date construction began, (ii) projected or actual completion date, (iii) square footage, (iv) physical description of the structure, (v) purpose of the structure, (vi) estimated cost; and (b) what are the details of all renovations which began at the property since November 4, 2015, including (i) start date, (ii) projected or actual completion date, (iii) structure, (iv) project description, (v) estimated cost?

Q-444² — May 11, 2020 — — With regard to evaluating the stock status of all of Canada’s fisheries resources since 2000: (a) has the Department of Fisheries and Oceans (DFO) used indicators to evaluate the various stocks and, if so, what is the breakdown of indicators by (i) species, (ii) province, (iii) area, (iv) sub-area, (v) year;?(b) if the answer to (a) is negative, what does the DFO use as a basis for (i) evaluating stocks, (ii) making decisions on fisheries management; (c) has the DFO assessed the quality of its estimates for all of the various stocks and, if so, what is the breakdown of this qualitative assessment by (i) species, (ii) province, (iii) area, (iv) sub-area, (v) year; (d) if the answer to (c) is negative, (i) are there plans to carry out this assessment, (ii) why is this type of assessment not conducted; (e) has the DFO put together an action plan to increase the number of indicators used for evaluating various stocks and, if so, what are the names, measures taken or considered, and conclusions, broken down by (i) species, (ii) province, (iii) area, (iv) sub-area, (v) year; (f) if the answer to (e) is negative, (i) is this type of action plan being considered, (ii) why is there no action plan on this issue; (g) has the DFO expended funds to increase the number of indicators for evaluating the various stocks and, if so, what is the spending breakdown by (i) species, (ii) province, (iii) area, (iv) sub-area, (v) year; (h) if the answer to (g) is negative, (i) are there plans for this type of expenditure, (ii) why is there a lack of spending on this issue; (i) has the DFO begun to “rapidly develop or update the biological knowledge essential for the sustainable management” of lobsters in areas 15, 16, 17 and 18, as recommended in Science Advisory Report 2019/059, and, if so, what is the breakdown of measures taken by (i) area, (ii) sub-area, (iii) year; (j) if the answer to (i) is negative, (i) are there plans to do so, (ii) why have no measures been taken; (k) can the DFO explain why the confidence limit has increased to 95% in the past 10 years regarding the evaluation of the estimated biomass of stock in NAFO 4T and, if so, what is the explanation; and (l) if the answer to (k) is negative, why is the DFO unable to explain this increase?

Q-445² — May 11, 2020 — — With regard to the peer review process coordinated by the Canadian Science Advisory Secretariat (CSAS) for the Department of Fisheries and Oceans (DFO): (a) exactly how is the peer review process carried out; (b) is participation in science advisory meetings by invitation only and, if so, (i) why is this the case, (ii) how are peers selected, (iii) who is responsible for peer selection or, if not, what is the procedure for participating in meetings; (c) in advance of a science advisory meeting, do all peers receive (i) the preliminary study and, if so, how long do they have to review it or, if not, what are the reasons for this decision, (ii) the data for this study and, if so, how long do they have to review it or, if not, what are the reasons behind this decision; (d) is it possible for an individual or a group to express their views (i) without having been invited and, if so, what is the procedure to follow or, if not, what are the reasons for this decision, (ii) without attending the science advisory meetings despite having been invited and, if so, what is the procedure to follow or, if not, what are the reasons for this decision, (iii) without attending the science advisory meetings and without having been invited and, if so, what is the procedure to follow or, if not, what are the reasons for this decision; (e) is it possible to attend meetings as an observer and, if so, (i) what is the procedure to follow, (ii) is an invitation required or, if not, what are the reasons for this decision; (f) for each of the DFO peer review processes coordinated by the CSAS, what is the breakdown for each meeting since 2010 by number of representatives affiliated with (i) DFO, (ii) the federal government excluding DFO, (iii) the Government of Quebec, (iv) the Government of British Columbia, (v) the Government of Alberta, (vi) the Government of Prince Edward Island, (vii) the Government of Manitoba, (viii) the Government of New Brunswick, (ix) the Government of Nova Scotia, (x) the Government of Newfoundland and Labrador, (xi) the Government of Ontario, (xii) the Government of Saskatchewan, (xiii) the Government of Nunavut, (xiv) the Government of Yukon, (xv) the Government of Northwest Territories, (xvi) band councils, (xvii) a Quebec university, (xviii) a Canadian university, (xix) an American university, (xx) the non-Indigenous fishing industry, (xxi) the Indigenous fishing industry, (xxii) an Indigenous group not affiliated with the fishing industry, (xxiii) an environmental group, (xxiv) a wildlife protection group, (xxv) another group; (g) how is consensus defined in the DFO peer review processes coordinated by the CSAS; (h) are stakeholders selected in order to encourage a lack of opposition to the conclusions put forward by the DFO; (i) do the procedures for the peer review process encourage a lack of opposition to the conclusions put forward by the DFO; and (j) does the methodology for the peer review process encourage a lack of opposition to the conclusions put forward by the DFO?

Q-446² — May 11, 2020 — — With regard to recreational fishing managed by the Department of Fisheries and Oceans (DFO) since 2000: (a) what is the total amount of revenue generated by the DFO from the sale of recreational licences, broken down by (i) year, (ii) federal entity, (iii) fishing area, (iv) sub-area, (v) species; (b) what is the total amount of spending by the DFO to support recreational fishing, broken down by (i) year, (ii) federal entity, (iii) fishing area, (iv) sub-area, (v) species; (c) what measures are being taken to ensure compliance with recreational fishing regulations, broken down by (i) year, (ii) federal entity, (iii) fishing area, (iv) sub-area, (v) species; (d) what is the average number of fishery officers dedicated specifically to overseeing recreational fishing, broken down by (i) year, (ii) federal entity, (iii) fishing area, (iv) sub-area, (v) species; (e) what technological tools are used to ensure compliance with recreational fishing regulations, broken down by (i) year, (ii) federal entity, (iii) fishing area, (iv) sub-area, (v) species; (f) what is the number of tickets issued by the DFO using technological tools, broken down by (i) year, (ii) federal entity, (iii) fishing area, (iv) sub-area, (v) technological tool; (g) what is the total amount of all tickets issued by the DFO using technological tools, broken down by (i) year, (ii) federal entity, (iii) fishing area, (iv) sub-area, (v) technological tool; and (h) what is the total amount of all recreational fishing tickets issued by the DFO, broken down by (i) year, (ii) federal entity, (iii) fishing area, (iv) sub-area, (v) species?

Q-447² — May 11, 2020 — — With regard to deputy ministers’ committees of the Privy Council Office, for fiscal years 2015-16, 2016-17, 2017-18, 2018-19 and 2019-20, broken down by individual committee: (a) what are the names and qualifications of each member; (b) what is the renumeration provided to members for service on committees, broken down by member; and (c) what are the expenses claimed by members while performing committee business, broken down by member?

Q-448² — May 11, 2020 — — With regard to regional development agencies (RDAs) and the April 17, 2020, announcement of “$675 million to give financing support to small and medium-sized businesses that are unable to access the government’s existing COVID-19 support measures, through Canada’s Regional Development Agencies”: (a) how much of the $675 million will each of the six RDAs be allocated; (b) for each RDA, how will the funds be made available to businesses, broken down by program; (c) for each answer in (b), what are the details for each program, broken down by (i) funding type, (ii) criteria for qualification, (iii) maximum allowable funding per applicant, (iv) application deadlines, (v) number of applicants received, (vi) number of approved applicants; and (d) for each applicant in (c), what are the details of the applicant, broken down by (i) name, (ii) location, (iii) North American Industry Classification System (NAICS) code, (iv) amount applied for, (v) amount approved, (vi) project status, (vii) federal electoral district?

Q-449² — May 11, 2020 — — With regard to business support measures in response to COVID-19 and audits by the Canada Revenue Agency (CRA) for tax evasion and aggressive tax avoidance, since March 11, 2020: (a) how many audits has the CRA conducted to ensure that businesses do not practise tax evasion and aggressive tax avoidance, broken down by the number of businesses; and (b) of the businesses that have been audited by the CRA in (a), how many have benefited from support measures and how many have been denied support measures because of tax evasion and aggressive tax avoidance?

Q-450² — May 11, 2020 — — With regard to the efforts of the Canada Revenue Agency (CRA) to combat tax evasion and abusive tax planning since March 1, 2016: (a) how many businesses have been identified by the CRA’s computer systems, broken down by (i) businesses linked to tax evasion, (ii) businesses linked to fraud or fraud indicators, (iii) businesses linked to abusive tax planning; (b) of the businesses identified in (a), how many applied for the Canada Emergency Wage Subsidy (CEWS); and (c) of the applications for the CEWS in (b), how many were approved, and how many were denied because of tax evasion and abusive tax planning practices?

Q-451² — May 11, 2020 — — With regard to the government’s response to the arbitrary arrests of Martin Lee and other pro-democracy leaders in Hong Kong: (a) has the Canadian Government objected to these arrests and, if so, what specific action has been taken to voice the objection; (b) what specific assurances, if any, has the government received that Canadian citizens in Hong Kong not be subject to arrest or harm in relation to the pro-democracy movement; and (c) how is Canada monitoring and ensuring that Hong Kong’s Basic Law is being upheld, including the rights, protections, and privileges it grants to democratic advocacy?

Q-452² — May 11, 2020 — — With regard to vehicles purchased by the government for the 2018 G7 summit: (a) how many vehicles were purchased; (b) at the time of purchase, what was the market value of each individual vehicle purchased; (c) how many of the vehicles in (a) were put up for sale by the government; (d) of the vehicles in (c), how many were sold; (e) what was the individual selling price for each vehicle sold; and (f) of the vehicles in (c), how many (i) remain, (ii) are still for sale, including the individual selling price, (iii) are being used by the government, (iv) are in storage?

Q-453² — May 11, 2020 — — With regard to the changes to the Canadian Surface Combatants (CSC) design and associated increase to the cost per ship and delay of the construction start time: (a) how many ships are specifically contracted for in the first phase of the contract with Irving Shipbuilding; (b) what is the most recent cost estimate for the first three ships as provided to the Assistant Deputy Minister (Material) and the Commander of the Royal Canadian Navy (RCN); (c) what are the specific design changes being considered that are expected to increase the size, capacity, speed, and weight of the Type T26 frigate from the original United Kingdom design; (d) who proposed each change and who approved the change(s) as being essential to the operations for the RCN; (e) what is the rationale given for each design change contemplated in terms of the risks to schedule and budget; (f) what, if any, are the specific concerns or issues related to costs, speed, size, weight and crewing of the T26 frigate design that have been identified by the Department of National Defence, third party advisors and any technical experts; (g) what are the current state of operations and technical requirements for the CSC; (h) what is the schedule for each (i) design change, (ii) contract approval, (iii) independent report from third party advisors, including the schedule for draft reports; (i) what is the cost for spares for each of the CSC; and (j) what is the cost of infrastructure upgrades for the CSC fleet?

Q-454² — May 11, 2020 — — With regard to the Arctic Off-Shore Patrol Ships (AOPS): (a) what are the operational requirements established by the Canadian Coast Guard (CCG) for the two additional ships; (b) will the two AOPS for the CCG require redesign or changes, and, if so, what will be the specific changes; (c) what will be the specific cost for the changes; (d) when and in what reports did the CCG first identify the need for AOPS; (e) has the CCG identified any risks or challenges in operating the two AOPS, and, if so, what are those risks; and (f) what will be the total estimated costs of the two AOPS to CCG?

Q-455² — May 11, 2020 — — With regard to the Royal Canadian Navy (RCN): (a) which surface platform in the RCN is deemed a warship and why has it obtained such a designation; (b) will the Joint Support Ship be a warship; (c) which specific characteristics will enable to Joint Support Ship to be a warship; (d) what are the RCN's definitions of interim operational capability (IOC) and full operational capability (FOC); (e) when will the first Joint Support Ship (JSS 1) achieve IOC and FOC; (f) when will the second Joint Support Ship (JSS 2) achieve FOC; and (g) what is the most recent cost projection identified to Assistant Deputy Minister (Material) for (i) JSS 1, (ii) JSS 2?

Q-456² — May 11, 2020 — — With regard to Canada's submarine fleet: (a) what was the total number of days at sea for each submarine in (i) 2018, (ii) 2019; (b) what was the total spent to repair each submarine in (i) 2018, (ii) 2019; (c) what is the estimated total cost of the current submarine maintenance plan to the submarines in (i) 2018, (ii) 2019, (iii) 2020, (iv) 2021; and (d) what are the projected future costs of maintenance of the submarine fleet until end of life?

Q-457² — May 11, 2020 — — With regard to the replacement of Canada's polar class icebreakers: (a) what is the (i) expected date of their replacement, (ii) roles for these new vessels, (iii) budget or cost for their replacement; and (b) what are the details relating to operating older icebreakers (such as the Louis S. St-Laurent and Terry Fox), including (i) expected years they will have to continue to operate before replacements are built, (ii) total sea days for each vessel in 2017, 2018, and 2019, (iii) total cost of maintenance in 2017, 2018, 2019 for each polar class vessel, (iv) planned maintenance cost of the vessels for each of the next five years, (v) total crews required to operate?

Q-458² — May 11, 2020 — — With regard to the government's plans to build 16 multipurpose vessels for the Canadian Coast Guard: (a) what are the technical operational requirements for each vessel; (b) for each contract awarded in relation to the vessels, what is the (i) expected budget, (ii) schedule, (iii) vendor, (iv) work description; and (c) for each vessel, what is the (i) total number of crew expected, (ii) expected delivery date, (iii) risks to cost or budget identified in the planning for these ships?

Q-459² — May 11, 2020 — — With regard to the government's profit policy relating to shipbuilding: (a) what risks has government evaluated related to guaranteed contracts for the (i) Arctic OffShore Patrol Ships (AOPS), (ii) Canadian Surface Combatants (CSC), (iii) Halifax class frigates, and what were the results of each evaluation; (b) what is the profit range offered to Irving Shipbuilding Inc. for its work on the (i) AOPS, (ii) CSC, (iii) Halifax class frigates; (c) what is the total profit offered for guaranteed work under the National Shipbuilding Strategy, broken down by each "cost plus" contract; and (d) what are the details of any third party review of Canada's profit policy related to the (i) AOPS, (ii) CSC?

Q-460² — May 11, 2020 — — With regard to the Canada Revenue Agency’s investigations into overseas tax evasion and the Panama Papers and Paradise Papers scandals: (a) how many of the companies currently under investigation have requested government assistance under the COVID-19 emergency measures; and (b) of the requests for assistance from the companies in (a), how many were (i) granted, (ii) denied?

Q-461² — May 11, 2020 — — With regard to the efforts of the Canada Revenue Agency (CRA) to fight tax evasion: (a) how many corporate groups, with one or more subsidiaries in one of the top 10 jurisdictions of the Financial Secrecy Index or the Corporate Tax Haven Index, has the CRA identified; (b) how many corporate groups that were implicated in financial or tax scandals or that received what would be considered illegal state aid has the CRA identified; (c) how many corporate groups have filled out a full report for each country, in keeping with the standard outlined by the Global Reporting Initiative; (d) how many corporate groups in (a), (b) and (c) have received or applied for federal government assistance; and (e) for the cases in (d), how many applications have been rejected by the government?

Q-462² — May 11, 2020 — — With regard to tax year 2020: (a) what are the projections for tax revenue to be assessed on taxable benefits paid to Canadians under each emergency measure proposed; (b) what are the low-end projections for each emergency measure, broken down by measure; (c) what are the high-end projections for each emergency measure, broken down by measure; and (d) what are the estimates or scenario-planning numbers of people applying for the Canada Emergency Response Benefit that fall within each tax bracket in Canada, broken down by each 2019 federal income tax bracket?

Q-463² — May 11, 2020 — — With regard to departmental defences against Canadian International Trade Tribunal rulings: how much has been spent on legal fees, broken down by (i) department, (ii) expense, (iii) case, (iv) internal legal resources, (v) external legal resources?

Q-464² — May 11, 2020 — — With regard to the government's campaign for a United Nations Security Council seat in 2021: how much has been spent on hospitality-related expenses, broken down by (i) date, (ii) item or service?

Q-465² — May 11, 2020 — — With regard to the response from Correctional Service of Canada (CSC) to COVID-19 outbreaks in its facilities, specifically the Mission Medium Institution in British Columbia and the Port Cartier Institution in Quebec: (a) what protocols and procedures were enacted, and when, in the Port-Cartier Institution once COVID-19 was detected; (b) what protocols and procedures were enacted, and when, in the Mission Medium Institution in British Columbia once COVID-19 was detected; (c) are there standard pandemic protocols and procedures that are synchronized across the national CSC organization; (d) if the answer to (c) is negative, why; (e) if the answer to (c) is affirmative, what are the differences between CSC’s response in the Port Cartier Institute when compared to CSC’s response in the Mission Medium Institution; (f) at the Mission Medium Institution, on what date was Personal Protective Equipment (PPE) provided to staff, and what type of PPE was distributed; (g) at the Mission Medium Institution, on what date was PPE provided to inmates, and what type of PPE was distributed; (h) at the Port Cartier Institution, on what date was Personal Protective Equipment (PPE) provided to staff, and what type of PPE was distributed; and (i) at the Port Cartier Institution, on what date was PPE provided to inmates, and what type of PPE was distributed?

Q-466² — May 11, 2020 — — With regard to the $305 million Indigenous Community Support Fund (ICSF) contained within the federal government’s COVID-19 Economic Response Plan, of which British Columbia First Nations were allocated $39,567,000 and British Columbia Métis were allocated $3,750,000: (a) how much funding was provided to each Indigenous band within or bordering Mission—Matsqui—Fraser Canyon, including Cook's Ferry, Skatin Nations, Douglas, Spuzzum, Ts'kw'aylaxw First Nation, Samahquam, Sts'ailes, Bridge River, Tsal'alh, Ashcroft, Boston Bar First Nation, Skawahlook First Nation, Sq'éwlets, Bonaparte, Nicomen, Leq' a: mel First Nation, Union Bar First Nation, Kanaka Bar, Siska, Oregon Jack Creek, Boothroyd, Xaxli'p, T'it'q'et, Matsqui, Shackan, Skuppah, Seabird Island, Chawathil, Yale First Nation, Cayoose Creek, Lytton, High Bar, and Stswecem'c Xgat'tem; (b) which existing agreements are being used to transfer those funds, broken down by band; (c) what reporting requirements are in place, broken down by band and by contribution agreement; (d) how are bands required to communicate to their members how emergency funds were spent; and (e) how are bands required to report to Indigenous Services Canada their receipts or a record of how funds were spent or disbursed to support band members?

Q-467² — May 21, 2020 — — With regard to government stockpiles of personal protective equipment (PPE): (a) what was the specific volume of PPE supplies in the stockpile as of February 1, 2020, broken down by item; (b) how many supplies of PPE were, destroyed, disposed of, or otherwise removed from the stockpile between January 1, 2016 to March 1, 2020; (c) what are the details of all instances in (b), including the (i) date, (ii) number of items removed, broken down by type of item, (iii) reason for removal; and (d) what are the details of each time items were added to the stockpile between January 1, 2016 to March 1, 2020, including the (i) date, (ii) items added, (iii) volume, (iv) financial value?

Q-468² — May 21, 2020 — — With regard to personal protective equipment (PPE) purchased since January 1, 2020: (a) how many items of PPE have been purchased; (b) what was the price of each item at the time of purchase, broken down by (i) date of purchase, (ii) item, (iii) the total amount of each type of PPE per transaction?

Q-469² — May 21, 2020 — — With regard to contaminated swabs and faulty or rejected N95 masks purchased by Public Services and Procurement Canada: (a) which suppliers provided these items; and (b) since January 1, 2016, what other purchases have been made by the government from these suppliers broken down by (i) date of purchase, (ii) item or service purchased, (iii) number of units of item or service purchased per transaction?

Q-470² — May 21, 2020 — — With regard to procurement of personal protective equipment (PPE) since January 1, 2020: (a) how many Advance Contract Award Notices (ACANs) relating to PPE have been posted; (b) for the ACANs in (a), (i) how many bidders were there for each notice, (ii) who were the bidders for each notice; and (c) who won each contract?

Q-471² — May 21, 2020 — — With regard to preparation and response to COVID-19: (a) which provinces and territories have signed the Multi-Lateral Information Sharing Agreement (MLISA), and on what dates were each of their signatures provided; (b) which provinces and territories have declined to sign the MLISA, on what dates were each of their refusals provided, and what objections did each raise to signing; (c) which provinces and territories have withdrawn from the MLISA since signing it, and on what dates were their withdrawals effective; (d) is the MLISA currently in force, and, if not, why not; (e) which provinces and territories have signed the Federal/Provincial/Territorial Memorandum of Understanding on the Sharing of Information During a Public Health Emergency (Sharing MOU), and on what dates were each of their signatures provided; (f) which provinces and territories have declined to sign the Sharing MOU, and on what dates were their refusals provided; (g) which provinces and territories have withdrawn from the Sharing MOU since signing it, and on what dates were their withdrawals effective; (h) is the Sharing MOU currently in force, and, if not, why not; (i) which provinces and territories are using the Public Health Agency of Canada’s (PHAC) COVID-19 Case Report Form; (j) what percentage of known COVID-19 cases in Canada were reported to the PHAC using its COVID-19 Case Report Form versus other means; (k) when the PHAC’s COVID-19 Case Report Form instructs to "report cases electronically using secure methods or fax”, which secure methods does the PHAC utilize, and which methods are used, broken down by provinces and territories; (l) what percentage of known COVID-19 cases reported to the PHAC were reported using fax or paper; (m) how many full-time equivalents does the PHAC employ or have on contract to enter COVID-19 case reports received by fax or paper into electronic means; (n) what is the shortest, longest, and average delay that the PHAC experiences when a COVID-19 case report is received by fax or paper before it is entered into electronic means; (o) what is the reason for the discrepancy between the total number of cases of COVID-19 reported by the Government of Canada on its “Coronavirus disease (COVID-19): Outbreak update” website, and the smaller number of cases with specific epidemiological data on the website entitled “Detailed confirmed cases of coronavirus disease”; (p) what are the factors that contribute to the delay between the reporting of the “episode date” of a COVID-19 case and the “date [the] case was last updated”, with reference to the data referred to in (o); (q) which provinces and territories have objected to the public disclosure of their detailed COVID-19 case data, as on the “Detailed confirmed cases of coronavirus disease” website, and for each province and territory, what are the details or summary of their objection; (r) why, in developing its COVID-19 Case Report Form, did the PHAC choose not to collect the ethnicity or race of individuals, as done in other jurisdictions; (s) why has the government never used its powers under section 15 of the Public Health Agency of Canada Act to better collect and analyze COVID-19 case data held by the provinces; (t) why has the PHAC not yet published an epidemiological model of COVID-19 that includes a scientifically detailed public disclosure of the modelling methodology, computer code, and input parameters; (u) what are the reasons that the PHAC does not publish a daily COVID-19 model that includes up-to-date estimates of the effective reproductive number (R), such as that produced by Norway, in its model of May 8, 2020; (v) what is the value, duration, objectives and deliverables of the contract issued by the Government of Canada to Blue Dot for the modelling of COVID-19, announced by the Prime Minister on March 23, 2020; (w) which other individuals or companies has the Government of Canada contracted for the modelling of COVID-19, and, for each contract, what is the (i) value, (ii) duration, (iii) objectives, (iv) deliverables; (x) do any of the contracts for COVID-19 limit the freedom of the contractors to disclose the information, methodology, or findings of their models as confidential, and, if so, which contracts are so affected, and what are the terms of the confidentiality; (y) what is the total amount of federal spending on the Panorama public health and vaccination data system since its launch; (z) which provinces and territories utilize Panorama’s disease outbreak management and communicable disease case management modules for reporting COVID-19 information to the federal government; (aa) to what extent does the federal government have access to COVID-19 outbreak and case data contained within the Panorama system and what are the reasons for the lack of access to data, if any; (bb) what steps has the federal government taken to ensure that, when data exists, it will have access to COVID-19 vaccination data contained within the Panorama system; (cc) to what extent does the Panorama system meet the data collection and reporting goals of the federal government’s report entitled “Learning from SARS – Renewal of Public Health in Canada”; and (dd) has an audit of the Panorama system been completed and, if so, what are the details of the audit’s findings, including when it was done, by whom it was conducted, and the standards by which it was measured?

Q-472 — May 21, 2020 — — With regard to preparation and response to COVID-19: (a) what are the reasons for the decision of the National Research Council (NRC) to grant a non-exclusive licence to the biotechnology company CanSino to utilize a modified cell line invented by the NRC; (b) under the licence referred to in (a), what compensation, consideration, or other reciprocal arrangements did the NRC receive or agree to from CanSino; (c) under the licence referred to in (a), did the NRC obtain from CanSino or others an agreement that the Government of Canada could receive or make use of any resulting COVID-19 vaccine, and, if so, what are the details of those agreements, including the cost and other compensation or consideration; (d) if the answer to (c) is negative, what are the reasons for the lack of such an agreement; (e) if there are costs to the NRC, or any other Government of Canada entity, payable to CanSino or any other entity, resulting from the provision or licence of a COVID-19 vaccine to the Government of Canada further to the licence referred to in (a), what are the details of those costs, and what are the reasons for agreeing to those costs; (f) under the licence referred to in (a), did the NRC obtain from CanSino or others an agreement that CanSino would furnish any resulting COVID-19 vaccine to developing countries on a not-for-profit basis, and, if not, what are the reasons; (g) what is the total amount of direct or indirect funding that has been provided by the Government of Canada to Gilead Sciences, Inc. for the research, development, manufacture, or clinical trials of remdesivir; (h) what is the total value of any funding, tax incentives or credits, or other arrangements made with Gilead Sciences, Inc. with regard to its Canadian manufacturing or research and development facilities, including to retrofit or build new Gilead facilities to scale-up production capacity, including the (i) amounts, (ii) dates, (iii) specific uses of those funds; (i) what are the details of each grant from the Government of Canada, or a related agency, made to any academic institution to conduct research on remdesivir, including the (i) value, (ii) recipients, (iii) dates, (iv) terms of each grant; (j) was any research and development on remdesivir conducted directly by the Government of Canada or any public servants or federal agencies, and, if so, (i) what is the budget of each research project, (ii) who conducted it, (iii) on what date; (k) does the Government of Canada own any patents on remdesivir or has the government licensed any patents on remdesivir and, if so, which patents and patent applications, including their numbers, and what are the details of any licensing agreements, including (i) to whom or from whom the licences were issued, (ii) on what dates, (iii) the terms of the licences; (l) has the Government of Canada secured or negotiated access to remdesivir, should it receive regulatory approval from Health Canada, and, if so, what price has been negotiated per treatment; (m) further to the Prime Minister’s announcement on April 7, 2020, that Canada would purchase up to 30,000 ventilators, how many ventilators has the Government of Canada ordered, on what date, from which supplier, at what price per ventilator, which models and manufacturers, and how many have been received by the federal government and each province; (n) for each type of ventilator ordered by the federal government, are they capable of providing mechanical ventilation as described by the ARDSnet protocol by, for example, controlling and limiting respiratory rate, tidal volume, peak pressures, positive end expiratory pressure (PEEP), and fraction of inhaled oxygen (FiO2); (o) which sources or officials, broken down by name or, if names will not be disclosed, by job title or position, provided technical advice related to the selection of ventilator models, modes, and capabilities in the context of COVID-19; (p) since 2016, what funds, broken down by year, were allocated to the National Emergency Strategic Stockpile (NESS) of personal protective equipment, how much of those funds allocated were not spent, if any, and, if applicable, for what reasons were those funds not spent; (q) as of January 1, 2020, February 1, 2020, March 1, 2020, and March 15, 2020, what quantities of personal protective equipment were in the NESS inventory, broken down by (i) masks, (ii) N95 respirators, (iii) gloves, (iv) other personal protective equipment; and (r) who at the Public Health Agency of Canada is presently responsible for stock rotation of the NESS inventory, and on what date was that individual tasked with that function?

Q-473 — May 21, 2020 — — With regard to preparation and response to COVID-19: (a) why did the Chief Public Health Officer (CPHO) state that the risk of COVID-19 to Canadians was “low”, following cabinet’s approval on February 17, 2020, of the statement that "the introduction or spread of [COVID-19] would pose an imminent and severe risk to public health in Canada”; (b) which officials, broken down by name or, if names will not be disclosed, by job title or position, drafted or approved the talking points for the CPHO that reads “the level of risk within Canada [...] remains low”, and which is contained in the Annotated Agenda for the federal, provincial and territorial (FPT) health ministers’ special call on novel coronavirus (2019-nCoV) of February 3, 2020; (c) which officials, broken down by name or, if names will not be disclosed, by job title or position, participated in formulating the conclusion of the Public Health Agency of Canada (PHAC) risk assessment in (b), and what professional credentials or higher education, and in which subjects, do each of these officials possess; (d) which officials, broken down by name or, if names will not be disclosed, by job title or position, drafted or approved the “Responsive, if asked [...]” talking points for the CPHO that are contained in the Annotated Agenda for the FPT health ministers’ special call on 2019-nCoV of February 10, 2020; (e) on which dates has the Minister of Health or her officials furnished advice or direction on the talking points of the CPHO, and what was the guidance or direction, in summary, in each case; (f) with respect to the role of the CPHO as an official advisor to the World Health Organization's (WHO) emergency committee regarding the outbreak of the 2019-nCoV, did the CPHO expressly recommend during the Emergency Committee meetings of January 22 and 23, 2020, that the WHO should immediately declare a Public Health Emergency of International Concern and, if not, why not; (g) with respect to the role of the CPHO as an official advisor to the WHO as noted in (f), did the WHO request the CPHO to agree to any form of confidentiality or non-disclosure, and, if so, did she agree in writing or otherwise; (h) on which dates did the government give notification to the WHO of COVID-19 and communicate information about the outbreak, as required under Articles 6 and 7 of the International Health Regulations, and what are the details of each such communication; (i) why did the PHAC refuse to support or collaborate in a research grant application to the Canadian Institutes of Health Research in which Professor Amir Attaran was to be a co-investigator, and only agree to participate once informed that Professor Attaran voluntarily removed his name from the application; (j) if the research grant application referred to in (i) is successful, does the government object to Professor Amir Attaran participating as a co-investigator and, if so, what are the reasons for the objection; (k) which officials, broken down by name or, if names will not be disclosed, by job title or position, ghost wrote, co-wrote, edited, or otherwise contributed to article by the Prime Minister entitled "Canada's vision for global health and gender equality” that appeared in The Lancet on April 28, 2018; (l) which of the contributors to the article referred to in (k) filed an author statement or International Committee of Medical Journal Editors (ICMJE) form with The Lancet, and what contributions or conflicts of interest did each disclose therein; (m) further to the article referred to in (k), did the Prime Minister file an author statement or ICMJE form with The Lancet and, if so, what contribution did he disclose, and what contributions or conflicts of interest did he disclose therein; (n) how much money was spent by the government in the researching, writing, and promotion of the article referred to in (k); and (o) further to the article referred to in (k), for what reasons was pandemic preparedness, or an analogous topic, not included?

Q-474 — May 21, 2020 — — With regard to the investigation into the leak of the Statistics Canada data relating to the April jobs numbers: (a) have ministerial staff been ordered to fully cooperate with the investigation, and, if not, why not; (b) who is conducting the investigation; (c) has the leak been referred to the RCMP, and, if not, why not; and (d) what is the full list of individuals outside of Statistics Canada who had access to the data prior to it being publicly released?

Q-475² — May 21, 2020 — — With regard to farm income loss as a result of the COVID-19 pandemic: (a) has Agriculture and Agri-Food Canada or Farm Credit Canada conducted an analysis on projected farm income loss as a result of the pandemic; and (b) what is the projected loss, broken down by agricultural sector?

Q-476² — May 21, 2020 — — With regard to physical distancing and other safety measures for ministerial vehicles and chauffeurs during the COVID-19 pandemic: (a) what specific measures have been put in place to ensure the safety of drivers, including whether (i) ministers are required to wear masks in the vehicles, (ii) there is an occupancy limit to the vehicles, (iii) specific seats within the vehicles may not be used, (iv) there is a prohibition on others, including ministerial exempt staff, riding in the vehicles, (v) any other measures have been made to limit close physical contact between drivers and ministers; (b) on what date was each measure listed in (a), (i) put into place, (ii) amended, (iii) rescinded; and (c) have any ministers required their drivers to drive outside of the National Capital Region since March 13, 2020, and, if so, what are the details of each trip, including (i) date of trip, (ii) destination, (iii) purpose of trip, (iv) number of occupants in the vehicle, (v) whether a minister was in the vehicle, (vi) specific safety precautions taken?

Q-477² — May 21, 2020 — — With regard to the Large Employer Emergency Financing Facility (LEEFF), since the creation of the program: (a) how many businesses have applied for the LEEFF; (b) how many businesses have been eligible; (c) how many applications from businesses have been denied; (d) of the applications that were denied, how many were from (i) businesses convicted of tax evasion, (ii) businesses convicted of abusive tax avoidance, (iii) companies that have subsidiaries in tax havens; (e) have applications from companies under investigation in connection with the Panama Papers and Paradise Papers been accepted; and (f) what is the current total cost of the LEEFF’s expenses, broken down by economic sector?

Q-478² — May 21, 2020 — — With regard to the Canada Revenue Agency (CRA) and tax havens: (a) what is the CRA's definition of tax haven; and (b) which jurisdictions have been identified as tax havens according to the CRA's definition?

Q-479² — May 21, 2020 — — With regard to the activities of the Canada Revenue Agency (CRA) under Part XVI of the Income Tax Act since November 2015, broken down by fiscal year and natural person, trust and corporation: (a) how many audits have been conducted; (b) how many notices of assessment have been issued by the CRA; and (c) what is the total amount recovered to date by the CRA?

Q-480² — May 21, 2020 — — With regards to Veterans Affairs Canada, broken down by year for the most recent ten fiscal years for which data is available: (a) what was the number of disability benefit applications received; (b) of the applications in (a), how many were (i) rejected (ii) approved (iii) appealed (iv) rejected upon appeal (v) approved upon appeal; (c) what was the average wait time for a decision; (d) what was the median wait time for a decision; (e) what was the ratio of veteran to Case Manager at the end of each fiscal year; (f) what was the number of applications awaiting a decision at the end of each fiscal year; and (g) what was the number of veterans awaiting a decision at the end of each fiscal year?

Q-481² — May 21, 2020 — — With regard to Veterans Affairs Canada (VAC): (a) during the most recent fiscal year for which data is available, broken down by month and by VAC offices, including nationally, what was the total number of overtime hours worked, further broken down by job title, including National 1st Level Appeals Officer, National 2nd Level Appeals Officer, Case Manager, Veterans Service Agent and Disability Adjudicator; (b) during the most recent fiscal year for which data is available, broken down by month and by VAC offices, including nationally, what was the average number of overtime hours worked, further broken down by (i) job title, including National 1st Level Appeals Officer, National 2nd Level Appeals Officer, Case Manager, Veterans Service Agent and Disability Adjudicator, (ii) directorate; (c) during the most recent fiscal year for which data is available, broken down by month and by VAC offices, including nationally, what was the total cost of overtime, further broken down by (i) job title, including National 1st Level Appeals Officer, National 2nd Level Appeals Officer, Case Manager, Veterans Service Agent and Disability Adjudicator, (ii) directorate; (d) during the most recent fiscal year for which data is available, broken down by month and by VAC offices, including nationally, what was the total number of disability benefit claims, further broken down by (i) new claims, (ii) claims awaiting a decision, (iii) approved claims, (iv) denied claims, (v) appealed claims; (e) during the most recent fiscal year for which data is available, broken down by month and by VAC offices, including nationally, how many new disability benefit claims were transferred to a different Veterans Affairs Canada office than that which conducted the intake; (f) during the most recent fiscal year for which data is available, broken down by month and by VAC offices, including nationally, what was the number of (i) Case Managers, (ii) Veterans Service Agents; (g) during the most recent fiscal year for which data is available, broken down by month and by VAC offices, including nationally, excluding standard vacation and paid sick leave, how many Case Managers took a leave of absence, and what was the average length of a leave of absence; (h) during the most recent fiscal year for which data is available, broken down by month and by VAC offices, including nationally, accounting for all leaves of absence, excluding standard vacation and paid sick leave, how many full-time equivalent Case Managers were present and working, and what was the Case Manager to veteran ratio; (i) during the most recent fiscal year for which data is available, broken down by month and by VAC offices, including nationally, how many veterans were disengaged from their Case Manager; (j) during the most recent fiscal year for which data is available, broken down by month and by VAC offices, including nationally, what was the highest number of cases assigned to an individual Case Manager; (k) during the most recent fiscal year for which data is available, broken down by month and by VAC offices, including nationally, how many veterans were on a waitlist for a Case Manager; (l) during the most recent fiscal year for which data is available, broken down by month and by VAC offices, including nationally, for work usually done by regularly employed Case Managers and Veteran Service Agents, (i) how many contracts were awarded, (ii) what was the duration of each contract, (iii) what was the value of each contract; (m) during the most recent fiscal year for which data is available, broken down by VAC offices, what were the service standard results; (n) what is the mechanism for tracking the transfer of cases between Case Managers when a Case Manager takes a leave of absence, excluding standard vacation and paid sick leave; (o) what is the department’s current method for calculating the Case Manager to veteran ratio; (p) what are the department’s quality assurance measures for Case Managers and how do they change based on the number of cases a Case Manager has at that time; (q) during the last five fiscal year for which data is available, broken down by month, how many individuals were hired by the department; (r) how many of the individuals in (q) remained employed after their 12-month probation period came to an end; (s) of the individuals in (q) who did not remain employed beyond the probation period, how many did not have their contracts extended by the department; (t) does the department track the reasons for which employees are not kept beyond the probation period, and, if so, respecting the privacy of individual employees, what are the reasons for which employees were not kept beyond the probation period; (u) for the individuals in (q) who chose not to remain at any time throughout the 12 months, were exit interviews conducted, and, if so, respecting the privacy of individual employees, what were the reasons, broken down by VAC offices; (v) during the last five fiscal years for which data is available, broken down by month, how many Canadian Armed Forces service veterans were hired by the department; (w) of the veterans in (v), how many remained employed after their 12-month probation period came to an end; (x) of the veterans in (v) who are no longer employed by the department, (i) how many did not have their employment contracts extended by the department, (ii) how many were rejected on probation; (y) if the department track the reasons for which employees are not kept beyond the probation period, respecting the privacy of individual veteran employees, what are the reasons for which veteran employees are not kept beyond the probation period; (z) for the veterans in (v) who chose not to remain at any time throughout the 12 months, were exit interviews conducted, and, if so, respecting the privacy of individual veteran employees, what were the reasons for their leaving, broken down by VAC offices; (aa) during the last five fiscal year for which data is available, broken down by month, how many employees have quit their jobs at VAC; and (bb) for the employees in (aa) who quit their job, were exit interviews conducted, and, if so, respecting the privacy of individual employees, what were the reasons, broken down by VAC offices?

Q-482² — May 21, 2020 — — With regard to the Canada Revenue Agency (CRA) and tax havens: Does the CRA consider the Cayman Islands and Barbados to be tax havens?

Q-483² — May 21, 2020 — — With regard to tax information exchange agreement signed between Canada and Cayman Islands, since entry into force of the agreement and broken down by fiscal year: (a) how many times has the Canada Revenue Agency (CRA) obtained information from Cayman Islands; (b) how many times has the CRA released information to Cayman Islands; (c) how much tax examinations abroad was conducted by CRA in Cayman Islands; (d) how many CRA enquiries have been denied by the Cayman Islands; (e) how many audits have been conducted by the CRA; (f) how many notices of assessment have been issued by the CRA; and (g) what is the total amount recovered by the CRA?

Q-484² — May 21, 2020 — — With regard to amendments to the Canada Grain Regulations (SOR/2020-63), enacted through the passage of Bill C-4, An Act to implement the Agreement between Canada, the United States of America and the United Mexican States, which amended the Canada Grain Act through an expedited process, bypassing the normal Canada Gazette I posting and public comment period, and were posted on Canada Gazette, Part II, Volume 154, Number 9: (a) what are the details of all meetings, round tables, teleconference calls, town halls, and other means of consultation, in regard to grain, held during CUSMA/NAFTA 2.0 negotiations, including the (i) dates, (ii) locations, (iii) agendas, (iv) minutes, (v) attendee and invitee lists, including government officials and agriculture sector stakeholders, and their organizational affiliations; (b) for the meetings referred to in (a), what are the details of (i) published notices, (ii) reports, including where and when they were published; (c) what are the details of all stakeholder views expressed during these consultations, including minority positions, which were communicated to inform the Government of Canada negotiating position, along with the names and positions of the officials to whom these stakeholder views were communicated; (d) what are the details of all engagement activities with grain sector stakeholders following the CUSMA announcement where the impacts of the agreement, potential legislative and regulatory amendments, and implementation plans were discussed, as well as the reports flowing from these engagement activities that informed the drafting of Bill C-4 amendments to the Canada Grain Act, including the (i) dates, (ii) locations, (iii) agendas, (iv) minutes, (v) attendees, including from the Canada Grain Commission and Agriculture and Agri-Food Canada officials and agriculture sector stakeholders, and their organizational affiliations; (e) who made the decision to have “minimal” consultation on the regulatory changes and an explanation of their rationale for the decision when, as the regulatory analysis document says, the amendments are consequential; and (f) what is the definition of the industry referred to when “industry-led” is used in regard to integrating the Delivery Declaration Form and its implementation into the existing grain delivery structure, particularly whether farmers are included among the leadership of the industry?


² Response requested within 45 days